We have therefore sought to test whether our atomistic simulations of BRCnA-RAD51 complexes might reveal information concerning the ability of cancer-associated BRCA2 alterations to affect the interaction between BRCA2 and RAD51. The gene discussed is BRCA2; the disease is cancer.